Journal List > J Cardiovasc Ultrasound > v.24(4) > 1018459

See the article "".
Yoon: The Incremental Effect of Obesity on Myocardial Fibrosis In Patients with Aortic Stenosis
REFER TO THE PAGE [Related article:] 303-311
There are many studies that show the myocardial fibrosis resulting from hypertension, aortic stenosis or hypertrophic cardiomyopathy, which are under the same condition with chronic pressure overloading.1)2)3)4) Multiple factors are recommended for impaired cardiac function in patients with hypertension, such as inflammation, adaptive ventricular remodeling, increased mechanical stress inducing subsequent ventricular hypertrophy, interstitial and perivascular fibrosis, endothelial dysfunction and neurohormonal factors.5)6)7)8)9)10)
The development of left ventricular (LV) hypertrophy is actually a combined consequence of chronic pressure or volume overload in hypertension or aortic stenosis. To compensate for chronic pressure overload in these subjects, LV wall thickness gradually increases in order to normalize wall stress, leading to concentric LV remodeling and hypertrophy.11)12)13) Activation of several biological processes including various hormones, growth factors and cytokines also contribute to protein genesis by promoting muscle cell growth, leading to structural alterations and remodeling.14)
We can inference the fatigue and essential compensatory mechanism of myocardium. The similar process can occur in obese patients. Moderate to severe cases of obesity was presented as leading to increased LV wall stress, compensatory LV hypertrophy and LV dysfunction. Alpert15) used a term of ‘obesity cardiomyopathy’ expressing the series of myocardial dysfunction. Compared with healthy lean individuals, increased epicardial adipose tissue in obese group is expected to result in more extensive fatty infiltration in the myocardium.16) They showed the correlation between incidence of atrial fibrillation and an excess adiposity and fibrosis in obesity with histologic demonstration. 17)
In this study, Ávila-Vanzzini et al.18) presented concomitant overweight and obesity (OW/O) leading to pathological LV remodeling in patients with aortic stenosis. The most interesting point is that the authors revealed histologic patterns correlated well with body mass index or global longitudinal strain (GLS). Although not all tissues were obtained due to safety implications for patients, they showed and definitized the myocardial change in the concrete. However, the assessment of the area of fibrosis or lipid vacuoles in 5 fields leaves an inaccurate possibility for objective calculation.
The other attractive point of this study is incremental effect of obesity on this histologic change. The authors tried to maximize the setting of myocardial dysfunction both with obesity and chronic pressure-overloading condition (aortic stenosis). GLS imaging is being accepted for objective tool for systolic cardiac function.19)20) In general, they reasonably placed the proper characters with compatible assessment tool to show the correlation of imaging and histologic pattern.

References

1. López B, Querejeta R, Varo N, González A, Larman M, Martínez Ubago JL, Díez J. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation. 2001; 104:286–291.
2. Liu YW, Lee WH, Lin CC, Huang YY, Lee WT, Lee CH, Tsai LM, Chen JH, Tsai WC. Left ventricular diastolic wall strain and myocardial fibrosis in treated hypertension. Int J Cardiol. 2014; 172:e304–e306.
3. Dusenbery SM, Lunze FI, Jerosch-Herold M, Geva T, Newburger JW, Colan SD, Powell AJ. Left ventricular strain and myocardial fibrosis in congenital aortic stenosis. Am J Cardiol. 2015; 116:1257–1262.
4. Saito M, Okayama H, Yoshii T, Higashi H, Morioka H, Hiasa G, Sumimoto T, Inaba S, Nishimura K, Inoue K, Ogimoto A, Shigematsu Y, Hamada M, Higaki J. Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2012; 13:617–623.
5. Lai YH, Lo CI, Wu YJ, Hung CL, Yeh HI. Cardiac remodeling, adaptations and associated myocardial mechanics in hypertensive heart diseases. Acta Cardiol Sin. 2013; 29:64–70.
6. Kass DA. Ventricular arterial stiffening: integrating the pathophysiology. Hypertension. 2005; 46:185–193.
7. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Agabiti-Rosei E. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004; 43:731–738.
8. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996; 275:1557–1562.
9. Kehat I, Molkentin JD. Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation. 2010; 122:2727–2735.
10. Hamdani N, Bishu KG, von Frieling-Salewsky M, Redfield MM, Linke WA. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction. Cardiovasc Res. 2013; 97:464–471.
11. Mayet J, Hughes A. Cardiac and vascular pathophysiology in hypertension. Heart. 2003; 89:1104–1109.
12. Barasch E, Reichek N. Left ventricular hypertrophy in asymptomatic nonsevere aortic stenosis: should we worry? Circ Cardiovasc Imaging. 2015; 8:e004104.
13. Shah AS, Chin CW, Vassiliou V, Cowell SJ, Doris M, Kwok TC, Semple S, Zamvar V, White AC, McKillop G, Boon NA, Prasad SK, Mills NL, Newby DE, Dweck MR. Left ventricular hypertrophy with strain and aortic stenosis. Circulation. 2014; 130:1607–1616.
14. de Simone G, Pasanisi F, Contaldo F. Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension. 2001; 38:13–18.
15. Alpert MA. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci. 2001; 321:225–236.
16. Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 2015; 11:363–371.
17. Pandit SV, Anumonwo J, Jalife J. Atrial fibrillation susceptibility in obesity: an excess adiposity and fibrosis complicity? Circ Res. 2016; 118:1468–1471.
18. Ávila-Vanzzini N, Fritche-Salazar JF, Vázquez-Castro NM, Rivera-Lara P, Pérez-Méndez O, Martínez-Herrera H, Gómez-Sánchez M, Aranda-Frausto A, Herrera-Bello H, Luna-Luna M, Arias Godínez JA. Echocardiographic and histologic correlation in patients with severe aortic stenosis: influence of overweight and obesity. J Cardiovasc Ultrasound. 2016; 24:303–311.
19. Tee MW, Won S, Raman FS, Yi C, Vigneault DM, Davies-Venn C, Liu S, Lardo AC, Lima JA, Noble JA, Emter CA, Bluemke DA. Regional strain analysis with multidetector CT in a swine cardiomyopathy model: relationship to cardiac MR tagging and myocardial fibrosis. Radiology. 2015; 277:88–94.
20. Kang SJ, Lim HS, Choi BJ, Choi SY, Hwang GS, Yoon MH, Tahk SJ, Shin JH. Longitudinal strain and torsion assessed by two-dimensional speckle tracking correlate with the serum level of tissue inhibitor of matrix metalloproteinase-1, a marker of myocardial fibrosis, in patients with hypertension. J Am Soc Echocardiogr. 2008; 21:907–911.
TOOLS
Similar articles